# Newsletter

```json
{
  "title": "LAI Weekly Intelligence: December 12, 2025",
  "intro": "This week's intelligence highlights significant advances in long-acting injectable technologies, with strategic partnerships driving innovation and positive clinical outcomes demonstrating the sector's momentum.",
  "tldr": [
    "Nanexa and Moderna forge strategic partnership to develop PharmaShell extended-release technology",
    "UZEDY demonstrates positive Phase 3 results, advancing extended-release injectable th

*Newsletter générée par Vectora Inbox – Powered by Amazon Bedrock*
